NCT02631655View on ClinicalTrials.gov

POSitron Emission Imaging Using 18F-FDOPA in Neurooncology

NACompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

June 30, 2020

Study Completion Date

June 30, 2020

Conditions
Glioblastoma
Interventions
OTHER

impact of device 18F-FDOPA PET on treatment decisions

Imagery device: impact of 18F-FDOPA PET imaging on treatment decisions for patients with high-grade gliomas with an uncertain diagnosis.

Trial Locations (1)

06000

Centre Antoine Lacassagne, Nice

All Listed Sponsors
lead

Centre Antoine Lacassagne

OTHER

NCT02631655 - POSitron Emission Imaging Using 18F-FDOPA in Neurooncology | Biotech Hunter | Biotech Hunter